CANDRIAM S.C.A. – BioMarin Pharmaceutical Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$28.22M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -15.00% | -58.73K shares | -4.23M | $84.77 | 332.89K |
Q2 2022 | share | Decrease | -5.24% | -21.64K shares | 591K | $82.87 | 391.63K |
Q1 2022 | share | Increase | +50.72% | 139.07K shares | 7.63M | $77.1 | 413.27K |
Q4 2021 | share | Decrease | -0.72% | -2K shares | 2.87M | $89.08 | 274.20K |
Q3 2021 | share | Increase | +156.12% | 168.36K shares | 12.34M | $77.29 | 276.20K |
Q2 2021 | share | Decrease | -69.88% | -250.18K shares | -21.16M | $83.44 | 107.84K |
Q1 2021 | share | 0.00% | 0 shares | -1.23M | $75.51 | 358.03K | |
Q4 2020 | share | Decrease | -2.66% | -9.78K shares | 3.41M | $87.69 | 358.03K |
Q3 2020 | share | Decrease | -0.49% | -1.82K shares | -17.61M | $76.08 | 367.81K |
Q2 2020 | share | Increase | +14.65% | 47.22K shares | 18.94M | $123.34 | 369.64K |
Q1 2020 | share | 0.00% | 0 shares | -612K | $84.5 | 322.41K | |
Q4 2019 | share | Decrease | -10.32% | -37.10K shares | 3.02M | $84.55 | 322.41K |
Q3 2019 | share | Decrease | -19.38% | -86.41K shares | -13.79M | $67.4 | 359.52K |
Q2 2019 | share | Decrease | -3.03% | -13.92K shares | -2.82M | $85.65 | 445.93K |
Q1 2019 | share | 0.00% | 0 shares | 1.69M | $88.83 | 459.85K | |
Q4 2018 | share | Increase | +13.83% | 55.85K shares | -20K | $85.15 | 459.85K |
Q3 2018 | share | Increase | +52.28% | 138.7K shares | 14.18M | $96.97 | 403.99K |
Q2 2018 | share | Increase | +26.45% | 55.5K shares | 7.98M | $94.2 | 265.29K |
Q1 2018 | share | 0.00% | 0 shares | -1.69M | $81.07 | 209.79K | |
Q4 2017 | share | Decrease | -9.97% | -23.24K shares | -2.98M | $89.17 | 209.79K |
Q3 2017 | share | Increase | +13.62% | 27.93K shares | 3.06M | $93.07 | 233.03K |
Q2 2017 | share | Increase | +11.70% | 21.49K shares | 2.51M | $90.82 | 205.1K |
Q1 2017 | share | Decrease | -2.54% | -4.79K shares | 512K | $87.78 | 183.61K |
Q4 2016 | share | Decrease | -20.74% | -49.30K shares | -6.38M | $82.84 | 188.4K |
Q3 2016 | share | Decrease | -3.80% | -9.39K shares | 2.76M | $92.52 | 237.70K |
Q2 2016 | share | Increase | +18.53% | 38.62K shares | 2.12M | $77.8 | 247.1K |
Q1 2016 | share | Decrease | -7.05% | -15.80K shares | -6.39M | $82.48 | 208.47K |